Mackenzie Financial Corp Sanofi Transaction History

Mackenzie Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$41.48 - $45.59 $611,954 - $672,589	-14,753 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$40.0 - $44.84 $23,240 - $26,052	581 Added 4.1%	14,753 $659,000
Q2 2018 Aug 13, 2018	BUY	$37.63 - $41.22 $83,689 - $91,673	2,224 Added 18.61%	14,172 $567,000
Q1 2018 May 14, 2018	BUY	$38.98 - $45.76 $155,608 - $182,673	3,992 Added 50.18%	11,948 $479,000
Q4 2017 Feb 13, 2018	BUY	$42.86 - $50.61 $340,994 - $402,653	7,956	7,956 $342,000

805

272M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $137B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.